Does sucrose analgesia promote physiologic stability in preterm neonates?

Area of Science:

• Neonatal care
• Pain management
• Developmental pediatrics

Background:

• Premature infants born before 31 weeks gestational age experience significant procedural pain.
• Effective pain management is crucial for physiological stability and long-term outcomes in neonates.
• Oral sucrose is a commonly used analgesic for procedural pain in infants.

Purpose of the Study:

• To evaluate the efficacy of 24% oral sucrose in managing procedural pain and improving physiological stability in preterm infants.
• To assess the impact of sucrose on salivary cortisol levels (stress marker) and pulse rate variability (physiological stability).

Main Methods:

• A double-blind, randomized controlled trial involving infants born <31 weeks gestational age.
• Infants received either 24% sucrose or sterile water (placebo) for painful procedures during the first week of life.
• Salivary cortisol and continuous pulse oximetry data were collected to measure stress and physiological stability.

Main Results:

• No significant differences were observed between the sucrose and placebo groups in salivary cortisol response to pain.
• Pulse rate variability did not differ between groups, indicating no significant effect on overall physiological stability.
• A correlation was found between pulse rate variability and sucrose dosage only in the high-dose sucrose group.

Conclusions:

• 24% oral sucrose did not demonstrate efficacy in reducing stress or improving physiological stability in preterm infants undergoing painful procedures.
• The findings suggest that sucrose may not be universally effective for all painful procedures in this vulnerable population.
• Further investigation into optimal dosing or alternative pain management strategies for preterm neonates is warranted.